Five, seven or ten? No – it’s not a trendy store for juniors… it is a real-life anti-estrogen treatment dilemma facing oncologists and their post-menopausal, ER+, early-stage, breast cancer patients. Standard of care is to take anti-estrogen treatment for at least the first 5 years after diagnosis to help prevent hormone-receptor positive breast cancer recurrences. […]
In a consensus report published last week, Endocrine therapy and related issues in hormone receptor‑positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG), the BCTEG addressed four gaps in current guidance for oncologists related to the most common form of breast cancer, estrogen receptor positive (ER+) early stage breast […]
So what are the experts saying about anti-estrogen therapy for pre-menopausal patients diagnosed with breast cancer? Late last year, three dynamic oncologists from the University of Wisconsin, Madison – Amye Tevaarwerk, MD; Kari Wisinski, MD; and Ruth O’Regan, MD – collaborated to publish a review about the history and current state of anti-estrogen treatment. for […]
You’ve gone through surgery. Now your doctor has you on tamoxifen and you’ve been experiencing side effects such as hot flashes, nausea and mood swings. You understand that tamoxifen reduces the risk of breast cancer recurrence, but you may be wondering if you can continue dealing with tamoxifen side effects for a full 10 years. Chances […]
Fighting cancer can be complicated. Whether you are just beginning your journey to fight estrogen receptor positive (ER+) breast cancer or are approaching your 5 year anniversary and are wondering what’s next, you have options to consider and discuss with your healthcare team.
To help supplement the conversations with your physician, below, we have included some helpful information and links from trusted sources about each stage in your journey to fight early stage ER+ breast cancer.